Subtopic Deep Dive

Aconitum Alkaloids Pharmacokinetics
Research Guide

What is Aconitum Alkaloids Pharmacokinetics?

Aconitum alkaloids pharmacokinetics studies the absorption, distribution, metabolism, and excretion of toxic diterpenoid alkaloids from Aconitum plants like Fuzi in vivo.

Research focuses on CYP450-mediated biotransformation, particularly CYP3A4/5 and CYP2D6, using LC-MS/MS for plasma profiling (Tang et al., 2011; 84 citations). Key alkaloids include aconitine, mesaconitine, and hypaconitine, with processing reducing toxicity via diester hydrolysis (Sun et al., 2011; 102 citations). Over 10 major papers document toxicokinetics and bioavailability strategies (Yang et al., 2018; 81 citations).

Curated Papers

Key Challenges

Why It Matters

Pharmacokinetic profiles predict toxicity risks and drug interactions for Aconitum in TCM, enabling safe dosing in cardiovascular and rheumatic treatments (Shaw, 2010; 186 citations). Yang et al. (2018; 81 citations) link toxicokinetics of diester-diterpenoids to Fuzi potency, guiding clinical optimization. Tang et al. (2011; 84 citations) identify CYP3A4/5 metabolism, informing interaction avoidance with common drugs.

Key Research Challenges

Narrow Therapeutic Window

Aconitum alkaloids exhibit high toxicity with low therapeutic doses, complicating safe clinical use (Shaw, 2010; 186 citations). Processing reduces but does not eliminate risks, requiring precise pharmacokinetic monitoring (Sun et al., 2011; 102 citations).

CYP450 Variability

Inter-individual differences in CYP3A4/5 and CYP2D6 activity affect aconitine metabolism rates (Tang et al., 2011; 84 citations). Genetic polymorphisms challenge predictive modeling for diverse populations.

Bioavailability Enhancement

Low oral absorption limits efficacy, demanding strategies like formulation changes (Yang et al., 2018; 81 citations). Tissue distribution studies reveal cardiac accumulation risks (Wada et al., 2004; 83 citations).

Essential Papers

Songorine promotes cardiac mitochondrial biogenesis via Nrf2 induction during sepsis

Yi Li, Yu-Fan Feng, Xiao-Tian Liu et al. · 2020 · Redox Biology · 215 citations

Toxicological Risks of Chinese Herbs

Deborah Shaw · 2010 · Planta Medica · 186 citations

As traditional Chinese medicine (TCM) has become more popular there have been increasing concerns about safety and potential toxicity of the Chinese materia medica (CMM) comprising plants, animal p...

Developing Traditional Chinese Medicine in the Era of Evidence-Based Medicine: Current Evidences and Challenges

Foon Yin Fung, Yeh Ching Linn · 2015 · Evidence-based Complementary and Alternative Medicine · 153 citations

Evidence-based medicine (EBM), by integrating individual clinical expertise with the best available clinical evidence from systematic research, has in recent years been established as the standard ...

Metabolomics study on Fuzi and its processed products using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition analysis

Hui Sun, Bei Ni, Aihua Zhang et al. · 2011 · The Analyst · 102 citations

The lateral root of Aconitum carmichaelii Debx is named "Fuzi" which is widely distributed across Asia and North America and has been used to relieve joint pain and treat rheumatic diseases for ove...

Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes

Lan Tang, Ling Ye, Chang Lv et al. · 2011 · Toxicology Letters · 84 citations

Effects of long-term administrations of aconitine on electrocardiogram and tissue concentrations of aconitine and its metabolites in mice

Kentaro Wada, Makoto Nihira, Hideyuki Hayakawa et al. · 2004 · Forensic Science International · 83 citations

Relationships between the Toxicities of Radix Aconiti Lateralis Preparata (Fuzi) and the Toxicokinetics of Its Main Diester-Diterpenoid Alkaloids

Mengbi Yang, Xiaoyu Ji, Zhong Zuo · 2018 · Toxins · 81 citations

The processed lateral root of Aconitum carmichaelii Deb (Aconiti Radix lateralis praeparata or Fuzi) is a potent traditional herbal medicine extensively used in treatment of cardiovascular diseases...

Reading Guide

Foundational Papers

Start with Shaw (2010; 186 citations) for toxicity context, then Tang et al. (2011; 84 citations) for CYP3A4/5 mechanisms, and Sun et al. (2011; 102 citations) for Fuzi metabolomics baselines.

Recent Advances

Study Yang et al. (2018; 81 citations) on diester toxicokinetics and Zhou et al. (2021; 74 citations) on aconitine cardiac effects.

Core Methods

Core techniques include UPLC-HDMS pattern recognition (Sun et al., 2011), recombinant CYP450 assays (Tang et al., 2011), and long-term tissue PK in mice (Wada et al., 2004).

How PapersFlow Helps You Research Aconitum Alkaloids Pharmacokinetics

Discover & Search

Research Agent uses searchPapers and exaSearch to find 50+ papers on Aconitum pharmacokinetics, then citationGraph on Tang et al. (2011) reveals CYP metabolism clusters. findSimilarPapers expands to related toxicokinetic studies like Yang et al. (2018).

Analyze & Verify

Analysis Agent applies readPaperContent to extract LC-MS/MS data from Sun et al. (2011), then runPythonAnalysis with pandas for pharmacokinetic parameter stats. verifyResponse (CoVe) and GRADE grading assess metabolism claims against Tang et al. (2011) evidence.

Synthesize & Write

Synthesis Agent detects gaps in CYP2D6 modeling via contradiction flagging across papers, while Writing Agent uses latexEditText, latexSyncCitations for Tang (2011), and latexCompile for dosing regimen tables. exportMermaid visualizes metabolic pathways.

Use Cases

"Plot aconitine plasma concentration-time curves from mouse studies"

Research Agent → searchPapers('aconitine pharmacokinetics mice') → Analysis Agent → readPaperContent(Wada 2004) → runPythonAnalysis(pandas curve fitting, matplotlib plots) → researcher gets PK parameter CSV and graphs.

"Draft LaTeX review on Fuzi processing effects on alkaloids"

Synthesis Agent → gap detection → Writing Agent → latexEditText(structure review) → latexSyncCitations(Sun 2011, Yang 2018) → latexCompile → researcher gets compiled PDF with figures.

"Find code for Aconitum metabolomics LC-MS analysis"

Research Agent → searchPapers('Fuzi metabolomics') → paperExtractUrls(Sun 2011) → paperFindGithubRepo → githubRepoInspect → researcher gets R scripts for UPLC-HDMS data processing.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(250+ Aconitum hits) → citationGraph → DeepScan(7-step verify on Tang 2011 CYP data) → structured toxicity report. Theorizer generates hypotheses on bioavailability enhancers from Yang (2018) toxicokinetics. DeepScan flags contradictions in cardiac accumulation (Wada 2004 vs. Sato 1979).

Try Doxa for Aconitum Alkaloids Pharmacokinetics Research

Frequently Asked Questions

What defines Aconitum alkaloids pharmacokinetics?

It covers ADME of alkaloids like aconitine from Fuzi, emphasizing CYP3A4/5 metabolism and LC-MS/MS profiling (Tang et al., 2011).

What are key methods used?

LC-MS/MS for plasma quantification, human liver microsomes for CYP assays, and toxicokinetic modeling in rodents (Sun et al., 2011; Wada et al., 2004).

What are major papers?

Shaw (2010; 186 citations) on TCM toxicity risks; Tang et al. (2011; 84 citations) on aconitine CYP metabolism; Yang et al. (2018; 81 citations) on Fuzi diester toxicokinetics.

What open problems exist?

Predicting human variability in CYP2D6 metabolism and developing non-toxic bioavailability enhancers remain unresolved (Tang et al., 2011; Yang et al., 2018).